-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, McVrb37z0mNm6KpSEM4Sg/uV0/lTjn/vqSKMVKtdGj/aUAkYfddW/zPKYwHGNoxy kcnRi9iukZjgrOiSeDNPaw== 0000950134-06-023114.txt : 20061214 0000950134-06-023114.hdr.sgml : 20061214 20061214061054 ACCESSION NUMBER: 0000950134-06-023114 CONFORMED SUBMISSION TYPE: FWP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20061214 DATE AS OF CHANGE: 20061214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GTX INC /DE/ CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: FWP SEC ACT: 1934 Act SEC FILE NUMBER: 333-127175 FILM NUMBER: 061275597 BUSINESS ADDRESS: STREET 1: 3 NORTH DUNLAP AVE 3RD FL STREET 2: VAN VLEET BUILDING CITY: MEMPHIS STATE: TN ZIP: 38163 BUSINESS PHONE: 901-523-9700 MAIL ADDRESS: STREET 1: 3 N DUNLAP 3RD FLOOR VAN VIEEN BLDG CITY: MEMPHIS STATE: TN ZIP: 38163 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GTX INC /DE/ CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: FWP BUSINESS ADDRESS: STREET 1: 3 NORTH DUNLAP AVE 3RD FL STREET 2: VAN VLEET BUILDING CITY: MEMPHIS STATE: TN ZIP: 38163 BUSINESS PHONE: 901-523-9700 MAIL ADDRESS: STREET 1: 3 N DUNLAP 3RD FLOOR VAN VIEEN BLDG CITY: MEMPHIS STATE: TN ZIP: 38163 FWP 1 f25825fpfwp.htm FREE WRITING PROSPECTUS fwp
 

Issuer Free Writing Prospectus dated December 13, 2006
Filed Pursuant to Rule 433
Registration Nos. 333-139302 and 333-127175
(Relating to Preliminary Prospectus Supplement dated December 13, 2006)
FINAL PRICING TERMS
December 13, 2006
     
Issuer:
  GTx, Inc. (NASDAQ: GTXI)
 
    
Securities Offered:
  Common Stock
 
    
Maximum Number of Shares
  3,799,600 
 
    
Price Per Share
  $16.00 per Share
 
    
Estimated net Proceeds
  $57.35 million
 
    
Dilution
  Dilution per share to new investors will equal $13.23
The issuer has filed a registration statement (including a prospectus) and a preliminary prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively the issuer and the placement agents will arrange to send you the prospectus if you request it by calling 212-632-6717.

-----END PRIVACY-ENHANCED MESSAGE-----